Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why CRISPR Therapeutics Soared 13.8% Today

TheMotleyFool

0 0

Why CRISPR Therapeutics Soared 13.8% TodayPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Shares of CRISPR Therapeutics (NASDAQ: CRSP) jumped by 13.8% on Monday, after the clinical-stage biotech company announced some exciting news regarding one of its leading pipeline candidate, CTX001.

CTX001 is an investigational treatment for Sickle Cell Disease (SCD) and transfusion-dependent beta-thalassemia (TDT), both of which are rare blood disorders. Today, CRISPR Therapeutics reported that the U.S. Food and Drug Administration (FDA) granted CTX001 the Regenerative Medicine Advanced Therapy (RMAT) designation. This designation is reserved for drugs or treatments that meet three criteria.

Image Source: Getty Images.

Source Fool.com

Like: 0

CRSP

Teilen